Form 8-K - Current report:
SEC Accession No. 0001493152-25-004161
Filing Date
2025-01-29
Accepted
2025-01-29 16:43:17
Documents
33
Period of Report
2025-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39633
2 ex99-1.htm EX-99.1 29159
3 ex99-1_001.jpg GRAPHIC 255514
4 ex99-1_002.jpg GRAPHIC 581278
5 ex99-1_003.jpg GRAPHIC 391016
6 ex99-1_004.jpg GRAPHIC 290475
7 ex99-1_005.jpg GRAPHIC 329601
8 ex99-1_006.jpg GRAPHIC 254836
9 ex99-1_007.jpg GRAPHIC 253796
10 ex99-1_008.jpg GRAPHIC 382952
11 ex99-1_009.jpg GRAPHIC 321786
12 ex99-1_010.jpg GRAPHIC 394287
13 ex99-1_011.jpg GRAPHIC 364988
14 ex99-1_012.jpg GRAPHIC 320080
15 ex99-1_013.jpg GRAPHIC 199439
16 ex99-1_014.jpg GRAPHIC 218937
17 ex99-1_015.jpg GRAPHIC 163689
18 ex99-1_016.jpg GRAPHIC 358638
19 ex99-1_017.jpg GRAPHIC 521134
20 ex99-1_018.jpg GRAPHIC 297911
21 ex99-1_019.jpg GRAPHIC 322088
  Complete submission text file 0001493152-25-004161.txt   8814145

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE ibo-20250129.xsd EX-101.SCH 3033
23 XBRL LABEL FILE ibo-20250129_lab.xml EX-101.LAB 34240
24 XBRL PRESENTATION FILE ibo-20250129_pre.xml EX-101.PRE 24178
35 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3493
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42212 | Film No.: 25569949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)